IEMCA
Emilia-Romagna, IT
@iemcafeeders
Quick actions
SKU RKL6B-479633-63-1
7H-Pyrrolo[2,3-d]pyrimidine,4-chloro-7-[(4-methylphenyl)sulfonyl]-
Classification: Pharmaceutical Intermediates Cas NO.: 479633-63-1 Molecular Form
Drugs & Pharmaceutical Chemicals
Price on request
No public price on this one — ask the supplier for a quote.
Details
Stability: null
Tofacitinib Citrate Intermediate. Tofacitinib (INN) is a drug of the janus kinase (JAK) inhibitor class, discovered and developed by the National Institutes of Health and Pfizer. Tofacitinib citrate is marketed as Xeljanz and Jakvinus.